Search Results - "Dan J. Siskind"

Refine Results
  1. 1

    Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis by Siskind, Dan J, Leung, Janni, Russell, Anthony W, Wysoczanski, Daniel, Kisely, Steve

    Published in PloS one (15-06-2016)
    “…Although clozapine is the gold-standard for treatment refractory schizophrenia, it has the worst metabolic profile of all antipsychotics. This is partly…”
    Get full text
    Journal Article
  2. 2

    Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis by Siskind, Dan J, Lee, Michael, Ravindran, Arul, Zhang, Qichen, Ma, Evelyn, Motamarri, Balaji, Kisely, Steve

    “…Background: Although clozapine is the most effective medication for treatment refractory schizophrenia, only 40% of people will meet response criteria. We…”
    Get full text
    Book Review Journal Article
  3. 3

    Mental health implications for older adults after natural disasters--a systematic review and meta-analysis by Parker, Georgina, Lie, David, Siskind, Dan J, Martin-Khan, Melinda, Raphael, Beverly, Crompton, David, Kisely, Steve

    Published in International psychogeriatrics (01-01-2016)
    “…Natural disasters affect the health and well-being of adults throughout the world. There is some debate in the literature as to whether older persons have…”
    Get more information
    Journal Article
  4. 4

    The Mental Health of Older Persons After Human-Induced Disasters: A Systematic Review and Meta-Analysis of Epidemiological Data by Siskind, Dan J., Ph.D, Sawyer, Emily, Lee, Irene, Lie, David C., M.B.B.S, Martin-Khan, Melinda, Ph.D, Farrington, Julia, Crompton, David, M.B.B.S, Kisely, Steve, Ph.D

    “…Background Older people are increasingly “in harm's way” following human-induced disasters (HIDs). There is debate in the literature as to the relative impact…”
    Get full text
    Journal Article
  5. 5

    Clozapine-Encapsulated Binary Mixed Micelles in Thermosensitive Sol-Gels for Intranasal Administration by Tan, Madeleine S A, Pandey, Preeti, Falconer, James R, Siskind, Dan J, Balmanno, Alexandra, Parekh, Harendra S

    Published in Gels (05-01-2022)
    “…(1) Background: Clozapine is the most effective antipsychotic. It is, however, associated with many adverse drug reactions. Nose-to-brain (N2B) delivery offers…”
    Get full text
    Journal Article
  6. 6

    Patterns of antipsychotic medication use in Australia 2002-2007 by Hollingworth, Samantha A., Siskind, Dan J., Nissen, Lisa M., Robinson, Maxine, Hall, Wayne D.

    “…Objective: Atypical antipsychotic medications that are primarily used to treat schizophrenia and bipolar disorder cost the Pharmaceutical Benefits Scheme (PBS)…”
    Get full text
    Journal Article
  7. 7

    A systematic review and meta‐analysis of the association between poor oral health and substance abuse by Baghaie, Hooman, Kisely, Steve, Forbes, Malcolm, Sawyer, Emily, Siskind, Dan J.

    Published in Addiction (Abingdon, England) (01-05-2017)
    “…Background and aims Substance use disorders are associated commonly with comorbid physical illness. There are fewer data on dental disease in these conditions,…”
    Get full text
    Journal Article
  8. 8

    Elevated clozapine levels associated with infection: A systematic review by Clark, Scott R, Warren, Nicola S, Kim, Gajin, Jankowiak, David, Schubert, Klaus Oliver, Kisely, Steve, Forrester, Tori, Baune, Bernhard T, Siskind, Dan J

    Published in Schizophrenia research (01-02-2018)
    “…Abstract Clozapine is the most effective anti-psychotic medication for treatment refractory schizophrenia. A growing number of case reports have linked…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study by Lind, Penelope A, Parker, Richard K, Northwood, Korinne, Siskind, Dan J, Medland, Sarah E

    Published in Schizophrenia bulletin (07-05-2024)
    “…The ClozaGene Study is a nationwide cohort of adults who have been treated with clozapine. While clozapine is indicated in the management of…”
    Get full text
    Journal Article
  11. 11

    Treatment of clozapine‐associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX) by Siskind, Dan J, Russell, Anthony W., Gamble, Clare, Winckel, Karl, Mayfield, Karla, Hollingworth, Sam, Hickman, Ingrid, Siskind, Victor, Kisely, Steve

    Published in Diabetes, obesity & metabolism (01-04-2018)
    “…Clozapine causes obesity and type 2 diabetes (T2DM). Glucagon‐like peptide‐1 (GLP‐1) receptor agonists (e.g. exenatide) can counter clozapine‐associated GLP‐1…”
    Get full text
    Journal Article
  12. 12

    Nose-to-brain delivery of antipsychotics using nanotechnology: a review by Tan, Madeleine S A, Parekh, Harendra S, Pandey, Preeti, Siskind, Dan J, Falconer, James R

    Published in Expert opinion on drug delivery (02-06-2020)
    “…Orally-administered antipsychotics are effective in the management of psychosis-related disorders although generation-specific adverse drug reactions (ADRs)…”
    Get more information
    Journal Article
  13. 13

    A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions by Tan, Madeleine S. A., Honarparvar, Faraz, Falconer, James R., Parekh, Harendra S., Pandey, Preeti, Siskind, Dan J.

    Published in Psychopharmacology (01-03-2021)
    “…Rationale Clozapine is the most effective antipsychotic for treatment-refractory schizophrenia for reducing positive psychotic symptoms. It is associated with…”
    Get full text
    Journal Article
  14. 14

    Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study by Tuesley, Karen M, Jordan, Susan J, Siskind, Dan J, Kendall, Bradley J, Kisely, Steve

    “…Objective: People with severe mental illness have similar cancer incidence, but higher mortality than the general population. Participation in cancer screening…”
    Get full text
    Journal Article
  15. 15

    Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis by Siskind, Dan J, Wu, Brian T, Wong, Tommy T, Firth, Joseph, Kisely, Steve

    Published in The Lancet. Psychiatry (01-09-2020)
    “…People with schizophrenia have higher rates of smoking than the general population, and lower quit rates. Several randomised controlled trials have…”
    Get full text
    Journal Article
  16. 16

    Frequency and quality of mental health treatment for affective and anxiety disorders among Australian adults by Harris, Meredith G, Hobbs, Megan J, Burgess, Philip M, Pirkis, Jane E, Diminic, Sandra, Siskind, Dan J, Andrews, Gavin, Whiteford, Harvey A

    Published in Medical journal of Australia (02-03-2015)
    “…Objectives: To describe the frequency, type and quality of mental health treatment among Australian adults with past‐year affective and/or anxiety disorders…”
    Get full text
    Journal Article
  17. 17

    Fabrication and Characterization of Clozapine Nanoemulsion Sol–Gel for Intranasal Administration by Tan, Madeleine S. A., Pandey, Preeti, Lohman, Rink-Jan, Falconer, James R., Siskind, Dan J., Parekh, Harendra S.

    Published in Molecular pharmaceutics (07-11-2022)
    “…Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia. However, it causes many adverse drug reactions (ADRs), which lead to poor…”
    Get full text
    Journal Article
  18. 18

    Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort by Lind, Penelope A, Siskind, Dan J, Hickie, Ian B, Colodro-Conde, Lucía, Cross, Simone, Parker, Richard, Martin, Nicholas G, Medland, Sarah E

    “…Objective: The Australian Genetics of Bipolar Disorder Study is a nation-wide cohort of adults living with bipolar disorder. The study aims to detect the…”
    Get full text
    Journal Article
  19. 19

    Anxiolytic, hypnotic and sedative medication use in Australia by Hollingworth, Samantha A, Siskind, Dan J

    Published in Pharmacoepidemiology and drug safety (01-03-2010)
    “…Purpose New sedative drugs have been marketed in Australia in the last few years. We examined the trends in the prescribing of subsidised anxiolytic, hypnotic…”
    Get full text
    Journal Article
  20. 20